Cancer Family
Connective and Soft Tissue Neoplasm
CI-CAN-00000010Explore in graph →
Non-malignant849 active trials17 approved drugs339 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000010Explore in graph →
Clinical trials
3,878 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03441360 | Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS) | completed | Phase 2 | 23 | Eisai Inc.INDUSTRY | 1 | Oct 5, 2022 | clinicaltrials |
| NCT03062943 | A Study of Nintedanib for LymphAngioleioMyomatosis (LAM)(LAM) | completed | Phase 2 | 30 | IRCCS MultimedicaOTHER | 1 | Sep 28, 2022 |
| clinicaltrials |
| NCT03258892 | Sarcoma Treatment Guide in Improving Self-Monitoring in Patients With Sarcoma Receiving Chemotherapy | completed | N/A | 64 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT00680992 | Study of Denosumab in Subjects With Giant Cell Tumor of Bone | completed | Phase 2 | 535 | AmgenINDUSTRY | 12 | Sep 22, 2022 | clinicaltrials |
| NCT01879085 | Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma(GemTax) | completed | Phase 1 / Phase 2 | 37 | Melissa Burgess, MDOTHER | 1 | Sep 21, 2022 | clinicaltrials |
| NCT02063022 | Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma(EW-1) | completed | Phase 3 | 278 | Italian Sarcoma GroupNETWORK | 1 | Sep 19, 2022 | clinicaltrials |
| NCT02727387 | Protocol for the Treatment of Metastatic Ewing Sarcoma(EW-2) | completed | Phase 2 | 155 | Italian Sarcoma GroupNETWORK | 1 | Sep 19, 2022 | clinicaltrials |
| NCT02307500 | Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy(RESOUND) | completed | Phase 2 | 82 | Istituto Clinico HumanitasOTHER | 1 | Sep 10, 2022 | clinicaltrials |
| NCT03627741 | A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors | completed | Phase 1 | 10 | Mayo ClinicOTHER | 1 | Aug 25, 2022 | clinicaltrials |
| NCT01462630 | Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma | completed | Phase 2 | 29 | Fox Chase Cancer CenterOTHER | 1 | Aug 19, 2022 | clinicaltrials |
| NCT02880020 | Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery | completed | Phase 2 | 36 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT04247425 | Progressive Resistance Training for the Improvement of Physical Function | completed | N/A | 10 | OHSU Knight Cancer InstituteOTHER | 1 | Aug 8, 2022 | clinicaltrials |
| NCT01061411 | Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 16 | Roswell Park Cancer InstituteOTHER | 2 | Aug 5, 2022 | clinicaltrials |
| NCT02325505 | Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma | completed | — | 200 | InCor Heart InstituteOTHER | 1 | Aug 4, 2022 | clinicaltrials |
| NCT05475938 | Application of Painting Analysis and Psychotherapy in Children With Bone Tumors | completed | N/A | 40 | Henan Cancer HospitalOTHER_GOV | 1 | Jul 29, 2022 | clinicaltrials |
| NCT01014598 | Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis | completed | Phase 1 | 11 | Roswell Park Cancer InstituteOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT01896778 | Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer | completed | N/A | 9 | Roswell Park Cancer InstituteOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT02071862 | Study of the Glutaminase Inhibitor CB-839 in Solid Tumors | completed | Phase 1 | 210 | Calithera Biosciences, IncINDUSTRY | 1 | Jul 20, 2022 | clinicaltrials |
| NCT03245450 | Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors | completed | Phase 1 / Phase 2 | 40 | Eisai Inc.INDUSTRY | 8 | Jun 28, 2022 | clinicaltrials |
| NCT02508532 | (NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors | completed | Phase 1 | 250 | Blueprint Medicines CorporationINDUSTRY | 10 | Jun 21, 2022 | clinicaltrials |
| NCT02342275 | Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma | completed | Phase 3 | 377 | West China HospitalOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT03810976 | A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or Leiomyosarcoma | completed | Phase 2 | 37 | Yonsei UniversityOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT05419414 | The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis | completed | N/A | 65 | Istanbul UniversityOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02831257 | AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas | completed | Phase 2 | 18 | Massachusetts General HospitalOTHER | 1 | Jun 13, 2022 | clinicaltrials |
| NCT02357810 | Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas | completed | Phase 2 | 178 | Northwestern UniversityOTHER | 1 | Jun 7, 2022 | clinicaltrials |
| NCT03275818 | Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma(ABRADES) | completed | Phase 2 | 69 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Jun 7, 2022 | clinicaltrials |
| NCT00634504 | Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze(LVPK) | completed | Phase 1 | 20 | BTG International Inc.OTHER | 1 | Jun 6, 2022 | clinicaltrials |
| NCT05400018 | Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients | completed | — | 1,041 | Genetron HealthINDUSTRY | 1 | Jun 6, 2022 | clinicaltrials |
| NCT03997747 | Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OS(CSSG-02) | completed | — | 38 | Peking University People's HospitalOTHER | 1 | Jun 3, 2022 | clinicaltrials |
| NCT05402865 | A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone | completed | — | 301 | Shanghai JMT-Bio Inc.INDUSTRY | 1 | Jun 2, 2022 | clinicaltrials |
| NCT04377360 | Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors | completed | N/A | 10 | Alpha Tau Medical LTD.INDUSTRY | 1 | Jun 1, 2022 | clinicaltrials |
| NCT03365791 | PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies | completed | Phase 2 | 76 | Novartis PharmaceuticalsINDUSTRY | 1 | May 27, 2022 | clinicaltrials |
| NCT01764360 | Strategies to Improve Kaposi Sarcoma (KS) Outcomes in Zimbabwe(SIKO) | completed | N/A | 1,024 | University of Colorado, DenverOTHER | 1 | May 26, 2022 | clinicaltrials |
| NCT00474448 | The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses | completed | — | 200 | University of British ColumbiaOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT02371369 | Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)(ENLIVEN) | completed | Phase 3 | 120 | Daiichi SankyoINDUSTRY | 12 | May 11, 2022 | clinicaltrials |
| NCT02659020 | A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma(ANNOUNCE 2) | completed | Phase 1 / Phase 2 | 310 | Eli Lilly and CompanyINDUSTRY | 10 | May 9, 2022 | clinicaltrials |
| NCT00346164 | Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma | completed | Phase 3 | 588 | Children's Oncology GroupNETWORK | 5 | Apr 28, 2022 | clinicaltrials |
| NCT02647619 | Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF | completed | Phase 4 | 80 | University Hospital, AkershusOTHER | 1 | Apr 26, 2022 | clinicaltrials |
| NCT00126672 | RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS | completed | Phase 2 | 36 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 25, 2022 | clinicaltrials |
| NCT02048722 | Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma | completed | Phase 2 | 31 | Northwestern UniversityOTHER | 1 | Apr 25, 2022 | clinicaltrials |
| NCT03188068 | Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma | completed | Phase 2 | 30 | West China HospitalOTHER | 1 | Apr 21, 2022 | clinicaltrials |
| NCT04836884 | Vascular Anomaly Pathology and Genomics Biopsy Study | completed | N/A | 3 | Mayo ClinicOTHER | 1 | Apr 21, 2022 | clinicaltrials |
| NCT02821507 | Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma | completed | Phase 2 | 70 | Leiden University Medical CenterOTHER | 2 | Apr 20, 2022 | clinicaltrials |
| NCT03103087 | LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 382 | Myovant Sciences GmbHINDUSTRY | 8 | Apr 20, 2022 | clinicaltrials |
| NCT03049735 | LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 388 | Myovant Sciences GmbHINDUSTRY | 6 | Apr 19, 2022 | clinicaltrials |
| NCT02239861 | TAA-Specific CTLS for Solid Tumors (TACTASOM) | completed | Phase 1 | 16 | Baylor College of MedicineOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT05028400 | Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery(LSCI-NSURG) | completed | N/A | 20 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT03404076 | Unifying Advanced Treatment With Advanced Imaging(GISTm3) | completed | — | 93 | Heidelberg UniversityOTHER | 1 | Apr 7, 2022 | clinicaltrials |
| NCT05093101 | The Prognostic Value of Serum Biomarkers in Osteosarcoma | completed | — | 600 | Istituto Ortopedico RizzoliOTHER | 1 | Apr 5, 2022 | clinicaltrials |
| NCT02076620 | L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours | completed | Phase 1 | 29 | Philogen S.p.A.INDUSTRY | 2 | Apr 4, 2022 | clinicaltrials |
Data updated 24 days agoSource updated Oct 5, 2022source: clinicaltrials